Secop has developed the technology for an ultra-low temperature mobile cooling system. This system is optimized for the last mile of distribution for the new generations of vaccines and offers mobile operation even in high ambient conditions such as in tropical regions.
This dedicated condensing unit features a compressor cascade solution with a MP2UVULTM (low stage) and a BD100CN (high stage) compressor and takes advantage of Secop’s experience in medical applications, vaccine solar freezers, and mobile solutions and combines all of these applications.
Battery-driven active cooling systems for mRNA-based vaccines provide many advantages compared to existing passive cooling (dry ice) transport boxes. Active systems offer temperature control, do not need huge quantities of dry ice, are re-usable, do not waste tons of CO2, and prevent vaccine wastage.
They are suitable for any distribution point, including in remote areas where the availability of CO2 cannot be guaranteed or ambient conditions are too severe.
Benefits:
- Safe active fully automated mobile solution based on a 2-stage speed controlled compressor cascade system with a flexible temperature range from -20°C to -86°C even in tropical ambient conditions (43°C)
- Ideal solution for mains voltage independent transport and storage of mRNA-based COVID-19 and Ebola vaccines and CGT specimens
- Low energy consumption and fast pull-down time using low GWP green hydrocarbon refrigerants
- Reliable and precise temperature setting and control and reduced risk of wasting temperature sensitive specimens and vaccines
- Reliable long-lasting system with low TCO life cycle
- Designed for AC/DC global voltage range and optimized for low grid areas
- Easy °CCD controller customization via Tool4Cool software
Please share the news
18
